Kelman-Lazarov Inc’s ResMed RMD Stock Holding History

Kelman-Lazarov Inc’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-190	Closed	-$12.2K	–	349
2016 Q3	$12.2K	Hold	190	–	–	0.01%	281
2016 Q2	$12.1K	Buy	+190	New	+$11.2K	0.01%	268

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Kelman-Lazarov Inc's RMD Position: Q4 2016 in Review

Kelman-Lazarov Inc sold out of ResMed (RMD) in Q4 2016, closing a stake of 190 shares — an estimated $12.2K sold.

Kelman-Lazarov Inc first reported a position in RMD in Q2 2016 and held it in 2 quarters. The position peaked at $12.2K in Q3 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

Kelman-Lazarov Inc reported no remaining ResMed position as of Q4 2016 after selling out during the quarter.
Kelman-Lazarov Inc sold 190 ResMed shares in Q4 2016, an estimated $12.2K.
Kelman-Lazarov Inc first reported a position in ResMed in Q2 2016 and held it in 2 quarters.
Kelman-Lazarov Inc's ResMed position peaked at $12.2K in Q3 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on Kelman-Lazarov Inc's 13F filing for Q4 2016, filed 17 Jan 2017.